SCHEMBL5530778

SCHEMBL5530778

C#Cc1ccc(NC(=O)c2cccc(OC)c2N(C=O)c2ccc(C=NN(C)C)cc2)nc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FGFR4 P22455 1/20 0.42
F10 P00742 1/20 0.36
KMT2A Q03164 6/20 0.36
MEN1 O00255 5/20 0.36
NPC1 O15118 7/20 0.35
RAB9A P51151 7/20 0.35
TP53 P04637 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 2/20 0.35
RXFP1 Q9HBX9 3/20 0.34
MAPT P10636 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MAPK1 P28482 2/20 0.33
ABCB1 P08183 1/20 0.33
ABCC1 P33527 1/20 0.33
PDE2A O00408 1/20 0.33
MITF O75030 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5538471 0.92 FGFR4 (0.40) FGFR4F10KMT2AMEN1NPC1
SCHEMBL5532502 0.92 FGFR4 (0.39) FGFR4F10KMT2AMEN1NPC1
SCHEMBL5535284 0.91 FGFR4 (0.39) FGFR4F10KMT2AMEN1NPC1
SCHEMBL5531792 0.91 FGFR4 (0.39) FGFR4F10KMT2AMEN1NPC1
SCHEMBL5533977 0.88 F10 (0.43) FGFR4F10KMT2AMEN1NPC1
SCHEMBL5531871 0.88 MAPT (0.44) KMT2AMEN1NPC1RAB9ATP53
SCHEMBL5532013 0.87 MEN1 (0.38) FGFR4F10KMT2AMEN1NPC1
SCHEMBL5534774 0.85 FGFR4 (0.43) FGFR4F10KMT2AMEN1NPC1
SCHEMBL5549369 0.84 RAB9A (0.43) F10KMT2AMEN1NPC1RAB9A
SCHEMBL5531693 0.82 FGFR4 (0.38) FGFR4F10KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312235-B2 Benzamide inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-12-25 US claimed
EP-1373194-B1 BENZAMIDE INHIBITORS OF FACTOR Xa MILLENNIUM PHARM INC (US) 2007-08-01 EP claimed
EP-1373194-A1 BENZAMIDE INHIBITORS OF FACTOR Xa Millennium Pharmaceuticals, Inc. (US) 2004-01-02 EP claimed
US-20030069250-A1 Benzamide inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. 2003-04-10 US claimed
WO-2002079145-A1 BENZAMIDE INHIBITORS OF FACTOR Xa MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-10-10 WO claimed
US-7312235-B2 Benzamide inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-12-25 US disclosed
EP-1373194-B1 BENZAMIDE INHIBITORS OF FACTOR Xa MILLENNIUM PHARM INC (US) 2007-08-01 EP disclosed
EP-1373194-A1 BENZAMIDE INHIBITORS OF FACTOR Xa Millennium Pharmaceuticals, Inc. (US) 2004-01-02 EP disclosed
US-20030069250-A1 Benzamide inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. 2003-04-10 US disclosed
WO-2002079145-A1 BENZAMIDE INHIBITORS OF FACTOR Xa MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069250-A1 Benzamide inhibitors of factor Xa SERPINC1, TFPI, F12 FGFR4 4054/4885F10 10/4885KMT2A 2096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.